ABSTRACT
Uterine fibroids are the most common pelvic tumors in the reproductive age and are associated with substantial morbidity for several women. For women who wish to preserve their fertility, conservative myomectomy represents the best surgical choice when medical therapy is inadequate. A minimally invasive procedure should always be the preferred option to improve patient satisfaction and to decrease perioperative morbidity. Robotic surgery was introduced to overcome some of the difficulties associated with laparoscopic surgery, especially as in regard to sutures of hysterotomy incisions. Robotic myomectomy is a safe and feasible technique and has outcomes similar to those of laparoscopic surgery. In selected patients, medical therapy prior to surgery can be useful to correct anemia, to improve the quality of life, and to decrease the volume of the leiomyomas. Patients must be aware of uterine rupture in case of subsequent pregnancy even if the risk seems to be very low.
